3,3-dimethyl-1-(3-pyridinyl)-1-butanamine, 95.0%, 1g

(R)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate, 95.0%, 100g

Methyl 1-bromocyclopropanecarboxylate, 95.0%, 25g

BENZYL 2-((TERT-BUTOXYCARBONYL)AMINO)ACETATE, 95.0%, 500mg

Ethyl(2-trimethylsilyl)acetate, 95%, 25g

SCO-PEG2-Maleimide>95.0%(HPLC)5mg

(1R,6S)-3-METHYL-3,8-DIAZABICYCLO[4.2.0]OCTANE DIHYDROCHLORIDE, 95.0%, 100mg

2-((2R,3R)-3-(tert-butyl)-4-methoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 95%,99%ee, 100mg

4,4'-Bis(trans-4-propylcyclohexyl)-2-fluorobiphenyl, 97.0%, 1g

Methyl 2-(3,5-dichlorophenoxy)-4-methylpentanoate, 97.0%, 100mg

Sulfate de lithium monohydraté, min 99 %, pa, 500 g, emballage plastique.

METHYL 3-HYDROXY-1-METHYL-CYCLOBUTANECARBOXYLATE, 95.0%, 100mg

1-(2-Amino-3-nitrophenyl)ethan-1-one, 98%, 250mg